M. I. Nandennavar, “Are taxane based regimens better than non-taxane fluoropyrimidine based regimens in advanced gastric cancer? Findings from an observational multicentre study, South India”, Int J Res Med Sci, vol. 9, no. 2, pp. 423–431, Jan. 2021.